This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Neuro-ophthalmology  • Radiologic Imaging  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Implications for Demonstrating Neuroprotection in Multiple Sclerosis

Elliot M. Frohman, MD, PhD; Fiona Costello, MD; Olaf Stüve, MD; Peter Calabresi, MD; David H. Miller, MD; Simon J. Hickman, MD; Robert Sergott, MD; Amy Conger, BA; Amber Salter, MPH; Kimberly H. Krumwiede, MA; Teresa C. Frohman, BA; Laura Balcer, MD; Robert Zivadinov, MD, PhD

Arch Neurol. 2008;65(1):26-35.

A major objective in multiple sclerosis therapeutics is to develop strategic targeting of specific injury pathways to provide neuroprotection and potentially even restoration. Here we underscore the potential utility of the anterior visual system for the purpose of modeling neuroprotection in response to novel therapies.

Author Affiliations: Departments of Ophthalmology (Dr E. M. Frohman), Neurology (Drs E. M. Frohman and Stüve and Mss Conger, Salter, and T. C. Frohman), and Biomedical Communications (Ms Krumwiede), University of Texas Southwestern Medical Center at Dallas; Division of Neurology, Department of Medicine, and Department of Ophthalmology, University of Ottawa, Ottawa, Ontario, Canada (Dr Costello); Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland (Dr Calabresi); NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, England (Drs Miller and Hickman); Department of Ophthalmology, Wills Eye Clinic, Thomas Jefferson University (Dr Sergott) and Departments of Neurology and Ophthalmology, University of Pennsylvania (Dr Balcer), Philadelphia; and Department of Neurology, Buffalo Neuroimaging Analysis Center, The Jacobs Neurological Institute, State University of New York at Buffalo (Dr Zivadinov). Dr Costello is now with the Department of Neurosciences, The University of Calgary, Calgary, Alberta, Canada.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinal architecture predicts pupillary reflex metrics in MS
Salter et al.
Mult Scler 2009;15:479-486.
ABSTRACT  

Picturing injury and recovery with diffusion tensor imaging: The eyes have it
Bermel and Fox
Neurology 2009;72:584-585.
FULL TEXT  

Contribution of White Matter Lesions to Gray Matter Atrophy in Multiple Sclerosis: Evidence From Voxel-Based Analysis of T1 Lesions in the Visual Pathway
Sepulcre et al.
Arch Neurol 2009;66:173-179.
ABSTRACT | FULL TEXT  

Retinal Imaging by Laser Polarimetry and Optical Coherence Tomography Evidence of Axonal Degeneration in Multiple Sclerosis
Zaveri et al.
Arch Neurol 2008;65:924-928.
ABSTRACT | FULL TEXT